Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Vaccination with ΔCD40L or Flagellin Gene-Modified T Cells Activates Dendritic Cells In Vivo and Induces a Potent Anti-Tumor Immune Response

Adham S Bear, Meghan M Turnis, PhD, Xiao-Tong Song, PhD, Russell Cruz, MD, An Lu, Stephen Gottschalk, MD, Cliona M Rooney, PhD, Aaron E Foster, PhD

Blood (2011) 118 (21): 1909.

https://doi.org/10.1182/blood.V118.21.1909.1909

Published: 2011

Journal Articles

Interferon γ limits the effectiveness of melanoma peptide vaccines

Hyun-Il Cho, Young-Ran Lee, Esteban Celis

Blood (2011) 117 (1): 135–144.

https://doi.org/10.1182/blood-2010-08-298117

Published: 2011

Includes: Supplemental data

Journal Articles

Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children.

Peter J. Lang, MD, Ingo Mueller, MD, Heiko Teltschik, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD

Blood (2007) 110 (11): 3076.

https://doi.org/10.1182/blood.V110.11.3076.3076

Published: 2007

Journal Articles

A Vaccination Regimen Incorporating the Synergistic Combination of CpG-Containing Oligodeoxynucleotides and IL-2 Can Elicit CD8+ T Cell Responses That Effect Anti-Tumor Immunity from T Cell Repertoires Undergoing Reconstitution by Homeostatic Peripheral Expansion after BMT.

James Kochenderfer, Christopher Chien, Jessica Simpson, Ronald Gress

Blood (2005) 106 (11): 61.

https://doi.org/10.1182/blood.V106.11.61.61

Published: 2005

Journal Articles

DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mice Following Sub-Lethal Irradiation and Immune Reconstitution.

Adi Diab, MD, Vanessa M. Hubbard, Adam Cohen, MD, Deonka Huggins, Adam Kochman, Jose A. Guevarra, MD, Manuel Engelhorn, PhD, Jedd D. Wolchok, MD, PhD, Marcel van den Brink, MD, PhD, Alan N. Houghton, MD, Miguel-Angel Perales, MD

Blood (2004) 104 (11): 3057.

https://doi.org/10.1182/blood.V104.11.3057.3057

Published: 2004

Journal Articles

DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mouse Models of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Adi Diab, MD, Miguel-Angel Perales, MD, Adam Cohen, MD, Vanessa M. Hubbard, Jeff Eng, Deonka Huggins, Manuel Engelhorn, PhD, Jose A. Guevarra, MD, Onder Alpdogan, MD, Jedd D. Wolchok, MD, PhD, Adam Kochman, Alan N. Houghton, MD, Marcel van den Brink, MD, PhD

Blood (2004) 104 (11): 304.

https://doi.org/10.1182/blood.V104.11.304.304

Published: 2004

Journal Articles

Synergism between CpG ODN and IL-2 Leads to Massive CD8 + T Cell Responses Against a Self-Antigen and Epitope-Specific Anti-Tumor Immunity.

Jim Kochenderfer, MD, Chris Chien, BS, Ronald Gress, MD

Blood (2004) 104 (11): 3239.

https://doi.org/10.1182/blood.V104.11.3239.3239

Published: 2004

Journal Articles

Synergy between tumor immunotherapy and antiangiogenic therapy

Smita Nair, David Boczkowski, Benjamin Moeller, Mark Dewhirst, Johannes Vieweg, Eli Gilboa

Blood (2003) 102 (3): 964–971.

https://doi.org/10.1182/blood-2002-12-3738

Published: 2003

NARROW

Vaccination with ΔCD40L or Flagellin Gene-Modified T Cells Activates Dendritic Cells In Vivo and Induces a Potent Anti-Tumor Immune Response

Interferon γ limits the effectiveness of melanoma peptide vaccines

Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children.

A Vaccination Regimen Incorporating the Synergistic Combination of CpG-Containing Oligodeoxynucleotides and IL-2 Can Elicit CD8+ T Cell Responses That Effect Anti-Tumor Immunity from T Cell Repertoires Undergoing Reconstitution by Homeostatic Peripheral Expansion after BMT.

DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mice Following Sub-Lethal Irradiation and Immune Reconstitution.

DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mouse Models of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Synergism between CpG ODN and IL-2 Leads to Massive CD8 + T Cell Responses Against a Self-Antigen and Epitope-Specific Anti-Tumor Immunity.

Synergy between tumor immunotherapy and antiangiogenic therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only